| 1 |
Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [J]. Lancet, 2012, 380(9859):2163-2196.
|
| 2 |
Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study [J]. Ann Rheum Dis, 2014, 73(7):1323-1330.
|
| 3 |
Long DL, Ulici V, Chubinskaya S, et al. Heparin-binding epidermal growth factor-1ike growth factor(HB-EGF)is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities [J]. Osteoarthritis Cartilage, 2015, 23(9):1523-1531.
|
| 4 |
Jia H, Ma X, Tong W, et al. EGFR signaling is critical for maintaining the superficial layer of articularcartilage and preventing osteoarthritis initiation [J]. Proc Natl Acad Sci U S A, 2016, 113(50):14360-14365.
|
| 5 |
Mobasheri A, Bondy CA, Moley, et al. Facilitative glucose transporters in articular chondrocytes. Expression, distribution and functional regulation of GLUT isoforms by hypoxia, hypoxia mimetics, growth factors and pro-inflammatory cytokines[J]. Adv Anat Embryol Cell Biol,2008,200:1p following vi, 1-84.
|
| 6 |
Buckwalter JA, Mankin HJ, Grodzinsky AJ. Articular cartilage and osteoarthritis[J].Instr Course Lect, 2005, 54:465-480.
|
| 7 |
Felson DT, Neogi T.Osteoarthritis: is it a disease of cartilage or of bone?[J]. Arthritis Rheum, 2004, 50(2):341-344.
|
| 8 |
Schneider MR, Sibilia M, Erben RG. The EGFR network in bone biology and pathology [J]. Trends EndocrinolMetab, 2009, 20(10):517-524.
|
| 9 |
Schneider MR, Wolf E. The epidermal growth factor receptor ligands at a glance [J]. J Cell Physiol, 2009, 218(3):460-466.
|
| 10 |
AppletonCT, UsmaniSE, MortJS, et al. Rho/ROCK and MEK/ERK activation by transforminggrowth factor-a induces articular cartilage degradation[J]. Lab Invest, 2010,90(1):20-30.
|
| 11 |
袁功武，兰生辉，刘曦明.表皮生长因子受体信号通路对骨折愈合的生物学作用[J].中国矫形外科杂志, 2018, 26(4):328-332.
|
| 12 |
袁功武，兰生辉，曾文波,等.吉非替尼对骨折愈合中I,II及X型胶原基因表达的影响[J].中国矫形外科杂志, 2018, 26(10):939-944.
|
| 13 |
Gschwind A, Fischer OM, Ullrich A. The discovery of receptor tyrosine kinases: targets for cancer therapy [J]. Nat Rev Cancer, 2004, 4(5):361-370.
|
| 14 |
Zhang X, Zhu J, Liu F, et al. Reduced EGFR signaling enhances cartilage destruction in a mouse osteoarthritis model [J]. Bone Res, 2014,5(2):14015.
|
| 15 |
Pest MA, Russell BA, Zhang YW, et al. Disturbed cartilage and joint homeostasis resulting from a loss of Mitogen-Inducible gene 6 in a mouse model of joint dysfunction [J]. Arthritis Rheumatol, 2014, 66(10):2816-2827.
|
| 16 |
Shepard JB, Jeong JW, Maihle NJ, et al. Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo [J]. Arthritis Res Ther, 2013, 15(3):R60.
|
| 17 |
Staal B, Williams BO, Beier F, et al. Cartilage-specific deletion of Mig-6 results in osteoarthritis-like disorder with excessive articular chondrocyte proliferation [J]. Proc Natl Acad Sci U S A, 2014, 111(7):2590-2595.
|
| 18 |
Roskoski R Jr. ERK1/2 MAP kinases: structure, function, and regulation [J]. Pharmacol Res, 2012, 66(2):105-143.
|
| 19 |
He P, Shen N, Gao G, et al. Periodic mechanical stress activates PKC delta-Dependent EGFR mitogenic signals in rat chondrocytes via PI3K-Akt and ERK1/2 [J]. Cell Physiol Biochem, 2016, 39(4):1281-1294.
|
| 20 |
Naik B, Kumar M, Khanna AK, et al. Clinico-histopathological study of varicose vein and role of matrix metalloproteinases-1,matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinase-1 in varicose vein formation [J]. Indian J Pathol Microbiol, 2016, 59(1):25-30.
|
| 21 |
Konstantinos C Tsolis, Ekaterini S Bei, Ioanna Papathanasiou,et al. Comparative proteomic analysis of hypertrophicchondrocytes in osteoarthritis[J].Clin Proteomics,2015,12(1):12.
|
| 22 |
Gehris AL, Stringa E, Spina J, et al. The region encoded by the alternatively splicedexon IIIA in mesenchymal fibronectin appears essential forchondrogenesis at the level of cellular condensation[J]. Dev Biol, 1997,190(2):191-205.
|
| 23 |
Takeda H, Inoue H, Kutsuna T,et al. Activation of epidermal growth factor receptor gene is involvedin transforming growth factor-?mediated fibronectinexpression in a chondrocyte progenitor cell line[J]. Int J Mol Med,2010,25(4):593-600.
|
| 24 |
刘艳，尹若峰，侯睿智. BMP-2诱导软骨细胞凋亡及增殖的研究[J].中华骨与关节外科杂志, 2016, 9(03):251-254.
|
| 25 |
Goggs R, Carter SD, Schulze-Tanzil G, et al. Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis [J]. Vet J, 2003, 166(2):140-158.
|
| 26 |
So T, Croft M. Regulation of PI-3-kinase and Akt signaling in T lymphocytes and other cells by TNFR family molecules [J]. Front Immunol, 2013, 4:139.
|
| 27 |
ShengZG, HuangW, LiuYX, et al.Ofloxacin induces apoptosis via β1 integrin-EGFR-Rac1-Nox2 pathway inmicroencapsulated chondrocytes[J]. Toxicol Appl Pharmacol, 2013,267(1):74-87.
|
| 28 |
Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis[J].Ann N Y Acad Sci, 2010. 1192:230-237.
|
| 29 |
Piel MJ, Kroin JS, Im HJ. Assessment of knee joint pain in experimental rodentmodels of osteoarthritis[J]. Methods Mol Biol, 2015,1226:175-181.
|
| 30 |
Henry SP, Jang CW, Deng JM, et al. Generation of aggrecan-CreERT2 knockin mice for inducibleCre activity in adult cartilage [J]. Genesis, 2009, 47(12):805-814.
|
| 31 |
Zhang X, Zhu J, Liu F, et al. Reduced EGFR signaling enhances cartilage destruction in a mouse osteoarthritis model [J]. Bone Res, 2014,5(2):14015.]
|
|
[Henry SP, Jang CW, Deng JM, et al. Generation of aggrecan-CreERT2 knockin mice for inducibleCre activity in adult cartilage [J]. Genesis, 2009, 47(12):805-814.
|
| 32 |
Bonnevie ED, Galesso D, Secchieri C, et al. Elastoviscous transitions of articular cartilage reveal a mechanism of synergy between lubricin and hyaluronic acid [J]. PLoS One, 2015, 10(11):e0143415.
|
| 33 |
Das S, Banquy X, Zappone B, et al. Synergistic interactions between grafted hyaluronic acid and lubricin provide enhanced wear protection and lubrication [J]. Biomacromolecules, 2013, 14(5):1669-1677.
|
| 34 |
Lim H, Kim HP. Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways [J]. Arch Pharm Res, 2011, 34(1):109-117.
|
| 35 |
Long DL, Loeser RF. p38gamma mitogen-activated protein kinase suppresses chondrocyte production of MMP-13 in response to catabolic stimulation [J]. Osteoarthritis Cartilage, 2010, 18(9):1203-1210.
|